Kernel is developing hardware and software for implantable devices for people with neurological and degenerative diseases like epilepsy, dementia and Alzheimer’s disease . Kernel plans to collect data from human clinical trials where patients have implantable devices . Kernel is researching how the brain carries out core functions. In the future, Kernel aims to use brain implants to augment human intelligence as a way of helping human intelligence co-evolve with artificial intelligence .
Kernel was founded by Bryan Johnson (CEO) and is a team of neuroscientists and engineers . Johnson previously founded Braintree and sold it to PayPal in 2013. Kernel acquired Kendall Research Systems’ (KRS) clinical development program and their neural interface technologies in 2017. They have also brought on KRS CEO and founder, neuroengineer Christian Wentz . Theodore Berger of University of Southern California is acting chief science officer. Ed Boyden (MIT) is chief scientific advisor and Adam Marblestone (MIT) is chief strategy officer .
Chief Strategy Officer
Chief Scientific Advisor
Acting Chief Science Officer
Inside the Race to Hack the Human Brain
Documentaries, videos and podcasts